Puma Biotechnology (PBYI) Net Margin (2017 - 2026)
Puma Biotechnology (PBYI) recorded Net Margin of 14.49% in Q2 2026, up 3.33 percentage points from 11.17% a year earlier and up 22.97 percentage points from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Net Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Puma Biotechnology's Net Margin came in at 11.52% as of Jun 30, 2026, down 8.83 percentage points year-over-year; for FY2025, it was 13.62%, up 0.49 percentage points from FY2024.
- Annual Net Margin has increased for eight straight years, with a five-year change of +40.27 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at 13.14% in FY2024 (+3.97 pp), 9.16% in FY2023 (+9.16 pp), 0.00% in FY2022 (+11.51 pp) and -11.51% in FY2021 (+15.15 pp).
- Quarterly Net Margin has ranged from -96.60% in Q3 2021 to 32.68% in Q4 2024 over the past five years.
- On a year-over-year basis, Net Margin rose in five of the last eight quarters, with an average year-over-year change of +4.16 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 95.97 percentage points in Q3 2022, against a drop of 34.61 percentage points in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -8.48% (Q1 2026), 17.77% (Q4 2025) and 16.23% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 14.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.49% |
| Mar 31, 2026 | -8.48% |
| Dec 31, 2025 | 17.77% |
| Sep 30, 2025 | 16.23% |
| Jun 30, 2025 | 11.17% |
| Mar 31, 2025 | 6.46% |
| Dec 31, 2024 | 32.68% |
| Sep 30, 2024 | 25.23% |
| Jun 30, 2024 | -9.62% |
| Mar 31, 2024 | -11.00% |
| Dec 31, 2023 | 17.00% |
| Sep 30, 2023 | 10.33% |
| Jun 30, 2023 | 3.90% |
| Mar 31, 2023 | 2.65% |
| Dec 31, 2022 | -8.54% |
| Sep 30, 2022 | -0.63% |
| Jun 30, 2022 | 15.74% |
| Mar 31, 2022 | -7.44% |
| Dec 31, 2021 | 7.63% |
| Sep 30, 2021 | -96.60% |
API Access
Puma Biotechnology Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();